S I Pai, Y-Y Lin, B Macaes, A Meneshian, C-F Hung and T-C Wu

Gene Ther 13: 464-477; advance online publication, December 8, 2005; doi:10.1038/sj.gt.3302694

Abstract | Full Text | PDF

RNA interference in embryonic stem cells and the prospects for future therapies 

A Heidersbach, A Gaspar-Maia, M T McManus and M Ramalho-Santos

Gene Ther 13: 478-486; advance online publication, February 16, 2006; doi:10.1038/sj.gt.3302723

Abstract | Full Text | PDF

Viral-based modelling and correction of neurodegenerative diseases by RNA interference 

C Raoul, S D Barker and P Aebischer

Gene Ther 13: 487-495; advance online publication, December 1, 2005; doi:10.1038/sj.gt.3302690

Abstract | Full Text | PDF

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? 

J Weiler, J Hunziker and J Hall

Gene Ther 13: 496-502; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302654

Abstract | Full Text | PDF

Induction of stable RNA interference in mammalian cells 

Bryan R Cullen

Gene Ther 13: 503-508; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302656

Abstract | Full Text | PDF

Target selectivity in mRNA silencing 

N Aronin

Gene Ther 13: 509-516; advance online publication, February 16, 2006; doi:10.1038/sj.gt.3302726

Abstract | Full Text | PDF

RNA knockdown as a potential therapeutic strategy in Parkinson's disease 

F P Manfredsson, A S Lewin and R J Mandel

Gene Ther 13: 517-524; advance online publication, November 3, 2005; doi:10.1038/sj.gt.3302669

Abstract | Full Text | PDF

RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases 

E M Denovan-Wright and B L Davidson

Gene Ther 13: 525-531; advance online publication, October 20, 2005; doi:10.1038/sj.gt.3302664

Abstract | Full Text | PDF

Antiviral RNAi therapy: emerging approaches for hitting a moving target- FREE

J N Leonard and D V Schaffer

Gene Ther 13: 532-540; advance online publication, September 22, 2005; doi:10.1038/sj.gt.3302645

Abstract | Full Text | PDF

The silent treatment: siRNAs as small molecule drugs FREE

D M Dykxhoorn, D Palliser and J Lieberman

Gene Ther 13: 541-552; advance online publication, January 5, 2006; doi:10.1038/sj.gt.3302703

Abstract | Full Text | PDF

Lentiviral-mediated delivery of siRNAs for antiviral therapy -FREE

K V Morris and J J Rossi

Gene Ther 13: 553-558; advance online publication, January 5, 2006; doi:10.1038/sj.gt.3302688

Abstract | Full Text | PDF

Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders -FREE

P A Campochiaro

Gene Ther 13: 559-562; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302653

Abstract | Full Text | PDF

Therapeutic short hairpin RNA expression in the liver: viral targets and vectors -FREE

D Grimm and M A Kay

Gene Ther 13: 563-575; advance online publication, February 2, 2006; doi:10.1038/sj.gt.3302727

Abstract | Full Text | PDF